Targeted Photodynamic Killing of Breast Cancer Cells Employing Heptamannosylated β-Cyclodextrin-Mediated Nanoparticle Formation of an Adamantane-Functionalized BODIPY Photosensitizer

ACS Appl Mater Interfaces. 2016 Dec 14;8(49):33405-33411. doi: 10.1021/acsami.6b13612. Epub 2016 Nov 30.

Abstract

The targeted delivery of a photosensitizer (PS) into specific cancer cells is an effective way to enhance the efficacy and minimize the side effects of photodynamic therapy. Herein, heptamannosylated β-cyclodextrin (β-CD) was used to mediate the formation of an adamantane (Ad)-functionalized BODIPY PS nanoparticle via strong β-CD/Ad complexation. The mannose-functionalized PS nanoparticles are selectively internalized by mannose-receptor-rich MDA-MB-231 breast cancer cells via receptor-mediated endocytosis, facilitating singlet oxygen generation to trigger apoptosis in cancer cells upon red-light irradiation. These nanoparticles exhibit excellent targeted delivery of the PS, leading to cancer cell death after irradiation both in vitro and in vivo.

Keywords: BODIPY; mannose-mediated targeting; photodynamic therapy; photosensitizer; supramolecular chemistry.

MeSH terms

  • Adamantane
  • Boron Compounds
  • Breast Neoplasms
  • Cell Death
  • Humans
  • Nanoparticles
  • Photochemotherapy
  • Photosensitizing Agents
  • beta-Cyclodextrins / chemistry*

Substances

  • 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
  • Boron Compounds
  • Photosensitizing Agents
  • beta-Cyclodextrins
  • Adamantane